BioCardia, Inc. (BCDA) vs Marker Therapeutics, Inc. (MRKR)
A side-by-side comparison of BioCardia, Inc. and Marker Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCDA
BioCardia, Inc.
$1.07HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
MRKR
Marker Therapeutics, Inc.
$1.02HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — BCDA vs MRKR
growth of $100 · dividends reinvested · last 10yBCDA -99.8% (-46.5%/yr)MRKR -98.3% (-33.4%/yr)MRKR compounded faster over this window
Log scale — wide-divergence pair
BCDA MRKR
BCDA vs MRKR: by the numbers
- •MRKR is the larger company ($17M vs $16M market cap).
- •Both run net losses; BCDA's is the smaller (0.00% vs -706.23% net margin).
Metrics side by side
Valuation
| Metric | BCDA | MRKR |
|---|---|---|
| P/S ratio | N/A | 13.79 |
| P/B ratio | 5.87 | 1.40 |
Profitability
| Metric | BCDA | MRKR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -706.23% |
| ROE | -271.81% | -71.57% |
| ROIC | -273.70% | -88.07% |
Growth (annualized)
| Metric | BCDA | MRKR |
|---|---|---|
| Total return CAGR (5Y) | -61.39% | -42.13% |
Frequently asked
- How have BCDA and MRKR total returns compared?
- Over the past 10 years, BCDA delivered -46.74% and MRKR delivered -33.25% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.